Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Improving Access to Breast Cancer Clinical Trials: An Expert Interview With Clinicians in a Communit
Link ID 5974
Title Improving Access to Breast Cancer Clinical Trials: An Expert Interview With Clinicians in a Communit
Url http://www.medscape.com/viewarticle/574534?src=rss
Description Community practitioners discuss the economics and logistics of running breast cancer clinical trials, demonstrating that with creativity and dedicated personnel, it can be done.
Medscape Hematology-Oncology
Category Articles > Business of Medicine
Keywords
Date May 23, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. FDA Finds Olanzapine Injectable "Not Approvable" for Schizophrenia
  Eli Lilly announced the FDA has found their injectable form of olanzapine "not approvable" because of ongoing concern about excessive sedation seen in some patients after injection. Medscape Medical News
Category:   Articles > Business of Medicine


2. A Reader and Author Respond to "Reforms for Rating Media: Disclosure, Not Censorship"
  A reader shares her ideas on how to reduce the impact of modern commercial mass media on health.
The Medscape Journal of Medicine
Category:   Articles > Business of Medicine


3. Just 3 Words: Plastics in Healthcare
  NANN 2007: Did you know that procedures like total parenteral nutrition infusion, exchange transfusions, and extracorporeal membrane oxygenation (ECMO) put infants at special risk?
Medscape Nurses
Category:   Articles > Business of Medicine


4. U.S. Panel Backs Proposed J&J Psoriasis Drug
  An experimental Johnson & Johnson drug should be approved for treating adults with moderate or severe psoriasis, a advisory panel unanimously ruled Tuesday. Reuters Health Information
Category:   Articles > Business of Medicine


5. Sanofi Says to Fight Class Action Bid
  Drugmaker Sanofi-Aventis, the target of a lawsuit seeking class-action status filed on behalf of shareholders, on Friday vowed to fight allegations it hid the side-effects of its anti-obesity drug Acomplia. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS